A Phase 1 Study to Evaluate EMP22 PD and EMP16 PK Versus Xenical ® in Healthy Volunteers
Condition:   Overweight or Obesity Interventions:   Drug: Xenical® vs EMP 22;   Drug: EMP 22 vs Xenical®;   Drug: EMP 16 vs Xenical® Sponsors:   Empros Pharma AB;   CTC Clinical Trial Consultants AB Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials

Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia
Condition:   Type 1 Hyperlipoprotenemia Interventions:   Drug: Orlistat;   Drug: Placebo Sponsor:   University of Texas Southwestern Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2023 Category: Research Source Type: clinical trials